The US faces a critical shortage of Adderall as demand for ADHD treatment surges while pharmaceutical supply plummets. Pharmacies nationwide struggle to fill prescriptions, forcing patients toward alternative medications and straining primary care resources.
·FDA has officially declared an Adderall shortage across the country
·Pittsburgh pharmacies and providers report ongoing difficulty accessing adequate stock
·Demand for stimulant medications continues rising while production cannot keep pace
·Patients and doctors are turning to alternative ADHD treatments as Adderall becomes unavailable
·Primary care systems are developing new toolkits and resources to manage the crisis
drawn from Pittsburgh Post-Gazette, Newsweek, ADDitude, Contemporary Pediatrics · updated 42d ago